Castle Biosciences (CSTL) Amortizatization of Intangibles (2018 - 2026)

Castle Biosciences has disclosed Amortizatization of Intangibles across 7 years of filings, most recently posting $454000.0 for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $454000.0, down 68.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.2 million (down 49.57% YoY), and the FY2025 annual result was $4.2 million, down 36.89% from the prior year.
• Amortizatization of Intangibles came in at $454000.0 for Q1 2026 at Castle Biosciences, down from $708000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $1.7 million in Q2 2024 to a low of $184000.0 in Q3 2022.
• The 5-year median for Amortizatization of Intangibles is $1.2 million (2023), against an average of $1.2 million.
• Across the five-year window, Amortizatization of Intangibles jumped 752.72% in 2023 and slumped 68.36% in 2026, its largest moves.
• Castle Biosciences' Amortizatization of Intangibles stood at $1.2 million in 2022, then jumped by 38.51% to $1.6 million in 2023, then retreated by 1.65% to $1.6 million in 2024, then slumped by 56.11% to $708000.0 in 2025, then tumbled by 35.88% to $454000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $454000.0 (Q1 2026), $708000.0 (Q4 2025), and $905000.0 (Q3 2025), per Business Quant data.